BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 32198567)

  • 1. Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
    Xu M; Cen M; Shen Y; Zhu Y; Cheng F; Tang L; Hu W; Dai N
    Dig Dis Sci; 2021 Feb; 66(2):568-576. PubMed ID: 32198567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
    Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W
    J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
    Sitkin S; Pokrotnieks J
    Dig Dis Sci; 2021 Mar; 66(3):925-927. PubMed ID: 33063190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis.
    Cao H; Xu M; Dong W; Deng B; Wang S; Zhang Y; Wang S; Luo S; Wang W; Qi Y; Gao J; Cao X; Yan F; Wang B
    Int J Cancer; 2017 Jun; 140(11):2545-2556. PubMed ID: 28187526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
    Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
    Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.
    Rau M; Stieger B; Monte MJ; Schmitt J; Jahn D; Frey-Wagner I; Raselli T; Marin JJ; Müllhaupt B; Rogler G; Geier A
    Inflamm Bowel Dis; 2016 Oct; 22(10):2382-9. PubMed ID: 27580383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
    Ikpa PT; Doktorova M; Meijsen KF; Nieuwenhuijze NDA; Verkade HJ; Jonker JW; de Jonge HR; Bijvelds MJC
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):47-60. PubMed ID: 31470114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.
    Sheng L; Jena PK; Hu Y; Liu HX; Nagar N; Kalanetra KM; French SW; French SW; Mills DA; Wan YY
    J Pathol; 2017 Dec; 243(4):431-441. PubMed ID: 28892150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism.
    Tawulie D; Jin L; Shang X; Li Y; Sun L; Xie H; Zhao J; Liao J; Zhu Z; Cui H; Wen W
    Phytomedicine; 2023 May; 113():154733. PubMed ID: 36870307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling.
    Yan S; Khambu B; Chen X; Dong Z; Guo G; Yin XM
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):973-997. PubMed ID: 33127558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota.
    Jin D; Huang K; Xu M; Hua H; Ye F; Yan J; Zhang G; Wang Y
    Gut Microbes; 2022; 14(1):2120744. PubMed ID: 36067404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
    Fu ZD; Klaassen CD
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary hyodeoxycholic acid exerts hypolipidemic effects by reducing farnesoid X receptor antagonist bile acids in mouse enterohepatic tissues.
    Watanabe S; Fujita K
    Lipids; 2014 Oct; 49(10):963-73. PubMed ID: 25189147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis.
    Spatz M; Ciocan D; Merlen G; Rainteau D; Humbert L; Gomes-Rochette N; Hugot C; Trainel N; Mercier-Nomé F; Domenichini S; Puchois V; Wrzosek L; Ferrere G; Tordjmann T; Perlemuter G; Cassard AM
    JHEP Rep; 2021 Apr; 3(2):100230. PubMed ID: 33665587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal High-Salt Diet Induces Gut Microbiota Dysbiosis, Bile Acid Homeostasis Disbalance, and NAFLD in Weanling Mice Offspring.
    Guo Q; Tang Y; Li Y; Xu Z; Zhang D; Liu J; Wang X; Xia W; Xu S
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34206629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia.
    Xu H; Fang F; Wu K; Song J; Li Y; Lu X; Liu J; Zhou L; Yu W; Yu F; Gao J
    Microbiome; 2023 Nov; 11(1):262. PubMed ID: 38001551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
    Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
    Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling.
    Qiu Y; Yu J; Li Y; Yang F; Yu H; Xue M; Zhang F; Jiang X; Ji X; Bao Z
    Ann Med; 2021 Dec; 53(1):508-522. PubMed ID: 33783283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.